Abstract:Human microbiome contains billions of microorganisms that play important roles in the biological system and different diseases. Due to its complexity, conventional culture-independent technology may underestimate the value of low-abundance bacteria, which calls for a highly efficient method for its enrichment and comprehensive analysis. In this study, we developed a recycling free-flow isoelectric focusing (RFFIEF) method-based electrophoresis method to separate salivary microbiome. First, we used Escherichia coli (DH5α) as a model for RFFIEF method development, which was focused in a narrow pH range (0.38 pH unit). The recovery rate was 80.81% with 5.85% relative standard deviation (n = 5). The optimized method was then adopted to separate the human salivary microbiome into 32 fractions, followed by 16S rRNA gene sequencing and metaproteomics analysis. After RFFIEF fractionation, we identified 508 bacterial genera, which increased by 225% on average (n = 3) when compared to the results before fractionation. We further compared the compositional change of microbiome in the saliva of lung cancer group (n = 22) and control group (n = 21) through RFFIEF. Quantitative results demonstrated that six bacterial genera were upregulated dramatically in the lung cancer group, while two genera were downregulated. Through qPCR verification in an independent sample set (n = 48), we confirmed that genus Granulicatella was significantly upregulated in the lung cancer group, whereas Pseudomonas was remarkably downregulated (p < 0.001). RFFIEF is an efficient and reproducible technology to fractionate the microbiome for its comprehensive analysis, which can be further applied to the in-depth study of the complex microbiomes and contribute to the discovery of disease-associated bacteria.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c02627?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c02627</a>.Detailed supporting materials and methods, workflow for the pretreatment of saliva microbiome, the recovery rate, morphology of E. coli before and after RFFIEF separation, number of identified salivary bacteria, Shannon rarefaction curve, SDS-PAGE of salivary microbial proteins, STAMP analysis of significantly different bacteria, pH gradient of RFFIEF fractions for salivary microbiome, Venn diagram of identified salivary microbiome, distribution bar plot, Venn diagram of bacterial genera from control and cancer groups, validation of Rothia, Venn diagram of identified salivary microbiome by sequencing and metaproteomics approach, demographic information on enrolled lung cancer patients and healthy subjects, salivary bacteria significantly enriched via RFFIEF, significantly different salivary bacteria between the lung cancer group and healthy group, 16S rRNA primers for qPCR, the identified microbial proteins, and list of species and their species-specific peptides that were uniquely identified in each fraction (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c02627/suppl_file/ac0c02627_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

In-Depth Metaproteomics Analysis of Oral Microbiome for Lung Cancer

Characterization of the lung microbiome and exploration of potential bacterial biomarkers for lung cancer

Characterizing microbiota and metabolomics analysis to identify candidate biomarkers in lung cancer

Alterations of lower respiratory tract microbiome and short-chain fatty acids in different segments in lung cancer: a multiomics analysis

Structure of gut microbiota and characteristics of fecal metabolites in patients with lung cancer

Characterization of Microbiota in Cancerous Lung and the Contralateral Non-Cancerous Lung Within Lung Cancer Patients

Integrative metagenomic, transcriptomic, and proteomic analysis reveal the microbiota-host interplay in early-stage lung adenocarcinoma among non-smokers

Identifications of the potential in-silico biomarkers in lung cancer tissue microbiomes

A metagenome association study of gut microbiome revealed biomarkers for chemotherapy efficacy in locally advanced and advanced lung cancer

Free-Flow Isoelectric Focusing for Comprehensive Separation and Analysis of Human Salivary Microbiome for Lung Cancer

Identification of microbial markers associated with lung cancer based on multi‐cohort 16 s rRNA analyses: A systematic review and meta‐analysis

Gut microbial metabolites in lung cancer development and immunotherapy: Novel insights into gut-lung axis

Disease-associated Gut Microbiome and Critical Metabolomic Alterations in Patients with Colorectal Cancer

Dynamic Changes of the Gut Microbiota and Its Functional Metagenomic Potential during the Development of Non-Small Cell Lung Cancer

The Composition Alteration of Respiratory Microbiota in Lung Cancer

Deep Metaproteomics Approach for the Study of Human Microbiomes

Metaproteomics characterizes human gut microbiome function in colorectal cancer

Oral Microbiome and CPT1A Function in Fatty Acid Metabolism in Oral Cancer

Quantitative Proteomic Analysis of Microdissected Oral Epithelium for Cancer Biomarker Discovery

Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolites

Association of gut microbiomes with lung and esophageal cancer: a pilot study